British pharmaceutical company GlaxoSmithKline announced that its drug appears to be effective against the new Omicron coronavirus strain. This is reported by Reuters.
This is an antibody-based drug. The conclusions about its effectiveness were made after initial laboratory tests.
GlaxoSmithKline hopes to complete testing of the drug by the end of the year to confirm its effectiveness against various mutations seen in the Omicron strain.